Identity and percentage holding of significant shareholders
| Substantial holdings | Shares held | % |
|---|---|---|
| Global Health Investment Fund I, LLC | 7,100,000 | 13.66% |
| Calculus Capital | 4,669,282 | 8.99%* |
| Spreadex Ltd | 2,624,354 | 5.05%** |
| Mr Hugh JJ Rylands | 1,686,603 | 3.73% |
| Directors and related shareholders | ||
| Ian Gilham | 503,174 | 0.97% |
| David Budd | 213,710 | 0.41% |
| Matthew Fowler | 99,457 | 0.19% |
| Tom Lindsay | 202,217 | 0.39% |
| Chris Yates | 41,304 | 0.08% |
| Total Directors' holdings | 1,060,362 | 2.04% |
| Total shares in issue | 51,986,071 | 100.00% |
The date this data was updated: 26/06/2020
* - DATE OF LAST NOTIFICATION
** - Note 803,553 of these shares are held via a CFD/Spreadbet
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 51,986,701.
Number of AIM securities not in public hands is 12,829,644 or 24.7%.
Latest reports
16 June 2020
Investor Presentation June 2020
Investor News
Thursday August 13, 2020
Small-cap healthcare stocks outperform, but can the momentum be maintained?
Saturday August 08, 2020
Small Cap Movers: Redx Pharma joins junior biotech success stories
Tuesday August 04, 2020
FTSE 100 finishes little changed as traders lack sentiment driver
This site uses cookies for tracking and statistical purposes. Please read our 